Overview

Abuse Potential of Sativex

Status:
Completed

Trial end date:
2008-06-01

Target enrollment:

Participant gender:

Summary

This crossover study with six treatment sessions is to evaluate the abuse potential of three doses of Sativex as compared to Marinol and placebo, in subjects with a history of recreational marijuana use.

Phase:

Phase 1

Details

Lead Sponsor:

GW Pharmaceuticals Ltd.

Treatments:

Dronabinol
Nabiximols